Thrombosis Research (2006) 118, |—VI THROMBOSIS ae os os ee RESEARCH wv 6 tele ELSEVIER intl.elsevierhealth.com/journals/thre Author Index—Volumes 117-118 (2006) Abbate, R., 118:495, 545 Babak Azimifar, S., 118:505 Boyabatli, M., 117:463 Abchee, A., 117:631 Babu, Y.S., 117:343 Bragulat, E., 117:235 Abe, Y., 117:671; 118:463 Bakken, A.M., 118:341 Bressollette, L., 118:691 Acar, K., 118:765 Bantia, S., 117:343 Brimble, K.S., 118:397 Accapezzato, D., 117:659 Bareford, D., 117:623 Brosnan, J.F., 117:283 Acsady, G., 117:639 Barnes, C., 118:67 Brosstad, F., 117:705 Akif Topcuoglu, M., 118:289 Basila, D., 117:49 Brotman, D.J., 118:247 Al Saleh, K., 118:409 Bassler, D., 118:107 Brown, M.D., 118:547 Alam, S., 117:631 Bateson, T., 117:379 Brozovic, V.V., 118:595 Albisetti, M., 118:95 Batsis, |., 118:611 Brugada, J., 117:235 Aldea, G.S., 117:689 Bauman, M., 118:113 Brunner, H.R., 118:229 Alessandrello Liotta, A., Bavani, N., 117:603 Buczko, W., 117:557 118:495 Becker, R.C., 117:439 Bulley, S.R., 118:27 Alexander, J.H., 117:439 Beer, J.H., 118:229 Burkholder, R., 117:211 Almenar, S.M., 117:487 Begum, S., 118:371 Bush, A.C., 118:529 Altinyollar, H., 117:463 Berberoglu, U., 117:463 Bussey, H.!., 117:155 Amato, S., 117:685 Berczi, V., 117:639 Butkiewicz, A.M., 118:199 An, M.O., 117:653 Berry, L., 118:741 Byun, Y., 117:419 Anagnostopoulos, A., 118:611 Berti, S., 118:487 Ando, Y., 117:647 Bhakta, V., 117:447 Caiafa, J.S., 118:699 Ansell, J., 117:45 Bhiladvala, P., 118:213 Calvo, J., 117:355 Antonucci, E., 118:495 Biagini, A., 118:487 Campbell, J., 117:279 Aoki, R., 117:529 Biesma, D., 118:595 Cannon Ill, R.O., 117:155 Apor, A., 117:639 Blanco, A.N., 118:269 Cardin, A.D., 117:333 Appert-Flory, A., 117:721 Blann, A.D., 117:623; 118:305, Carrier, M., 117:469 Araujo, G.R., 118:699 479 Carroll, R.C., 117:551 Arnason, T., 118:253 Blomback, B., 117:353 Carvajal, Z., 118:637 Arnesen, H., 118:297, 433 Blomback, M., 117:353 Cassimatis, D.C., 117:379 Arnold, C.S., 117:343 Bohec, C., 118:691 Castello, R., 117:487 Arocha-Pinango, C.L., 118:637 Boinot, C., 117:365 Cesar, J.M., 118:335 Athale, U.H., 118:137 Bombeli, T., 118:723 Cesare Guidi, G., 117:731 Atwood, J.E., 117:379 Bonduel, M.M., 118:85 Cesari, F., 118:545 Austin, H., 118:767 Bonnar, J., 117:283 Cesena, F.H.Y., 117:401 Avcu, F., 118:665 Boos, C.J., 118:301 Cha, S.H., 117:653 Avery, P., 118:501 Borgert, C.J., 117:123, 481 Chabielska, E., 117:557 Azar, S.T., 117:631 Borgert, S.A., 117:123 Chalikias, G.K., 118:221 Aznar, J., 117:355, 403, 487; Bouche, G., 117:365 Chalmers, E.A., 118:3 118:447 Bovill, E.G., 117:439 Chan, A., 118:741 doi:10.1016/S0049-3848(06)00382-3 H Author Index Chan, A.K.C., 118:1 Desai, D., 117:87 Fusegawa, Y., 117:615 Chan, T., 118:763 DeVeber, G., 118:67, 153 Fuster, C., 117:487 Chand, P., 117:343 Dhamija, A., 117:603 Chandler, W.L., 117:689 Dietrich-Neto, F., 118:699 Gabriel, F., 117:403; 118:447 Chen, C.-J., 118:235 Dighiero, P., 117:365 Gage, B., 117:155 Chen, C.-M., 118:235 Dirican, A., 117:249 Gage, B.F., 117:55 Chen, F., 117:579 Doh, H.-J., 118:353 Gangji, A.S., 118:417, 423 Chen, I|.-C., 118:235 Domanic, N., 117:249 Gavasso, S., 117:523 Chen, Y.-H., 118:439 Dominguez, M.P., 118:269 Gemitzis, K., 118:535 Chen, Y.-T., 118:619 Douketis, J.D., 118:381, 409 Gennari, L.C., 118:269 Cheng, G., 118:763 Dowling, N., 118:767 Georgoulis, |., 118:611 Cheng, K., 118:741 Doyle, J.J., 118:27 Germain, P., 118:691 Chi, H.S., 117:501 Dozier, A., 118:275 Gharib, M.|., 118:27 Chiang, T.M., 117:299 Dyke, C., 117:439 Giacci, L., 118:471 Chin, C.-H., 118:439 Dymicka-Piekarska, V., 118:199 Gianetti, J., 118:487 Choi, D.H., 117:653 Giannoglou, G., 118:535 Choi, Y.K., 117:653 Easton, L., 117:665 Giglioli, C., 118:495 Chong, 4.Y., 118:479 Edwards, S.J., 118:321 Gillespie, D.L., 117:379 Chou, P.-C., 118:439 Eijkhout, H.W., 118:313 Girod, J.P., 118:247 Christopher, M., 118:529 Eikvar, L., 118:433 Goldenberg, N.A., 118:771 Chung, K.-H., 118:353 Eisses, M.J., 117:689 Gombert, J.M., 117:365 Ciftci, O., 117:249 Ekmekci, H., 117:249 Gomes, M., 118:699 Clase, C.M., 118:385 Elder, R.F., 117:551 Grabenstein, J.D., 117:379 Clerico, A., 118:487 Elg, M., 117:429 Graham, C., 118:189 Collet, M., 118:691 Elman, E.E., 117:609 Graham, U.M., 118:275 Coll-Vinent, B., 117:235 Emst, E., $97:150 Greeno, E.W., 118:555 Contreras, M.T., 117:355 Espana, F., 117:355, 487 Greinacher, A., 117:507; Corella, D., 117:355 Estelles, A., 117:487 118:165 Costello, R., 117:211 Evangelisti, L., 118:545 Grezchnik, E., 117:665 Cotter, R., 117:211 Grollman, A.P., 117:185 Coyle, L.C., 117:379 Fahlen, M., 117:493 Grosso, S.H., 118:269 Craig Hooper, W., 117:211 Falciani, M., 118:495 Guias, B., 118:691 Cranston, J., 117:211 Fassas, A., 118:611 Guiral, V., 117:403; 118:447 Crowther, M.A., 118:417, 423 Favaloro, E.J., 117:665 Gupta, M., 118:247 Cruden, N.L.M., 118:189 Fedele, F., 117:659 Gurel, C., 117:249 Csako, G., 117:87 Fedi, S., 118:495, 545 Gustafsson, D., 117:429 Cylwik, D., 117:557 Fehr, J., 118:723 Findley, K.C., 117:123 Hack, C.E., 118:205 Da Luz, P.L., 117:401 Finelli, L.N., 117:379 Haddad, T.C., 118:555 Dahm, A.E.A., 118:281 Fischer, F., 117:721 Hagiwara, M., 117:569 D’Alessandro, M., 117:659 Fong, C., 118:741 Haida, M., 117:647 D’Alleva, A., 118:471 For the XaNADU-1B Investiga- Hammer, N.L., 117:551 Dam, M., 118:313 tors, 117:439 Han Lee, S., 117:591 Dauerman, H.L., 118:361 Forster, A.J., 118:253 Handa, M., 118:509 Davis, G.L., 118:263 Fox, K.A.A., 118:189 Hardig, B.M., 117:713 Daykin, H.J., 118:755 Framstad, T., 118:341 Harding, S.A., 118:189 De Aguiar, E.T., 118:699 Franchini, M., 118:177 Haribabu, B., 118:275 De Caterina, R., 118:471 Franco Gensini, G., 118:545 Harjola, V.-P., 118:573 De Luca, L., 117:659 Fraser, C.J., 117:279 Harrington, R.A., 117:439 De Moura, L.K., 118:699 Freestone, B., 117:231; Hart, R.G., 117:493 De Smet, P., 117:155 118:479 Hasan, A., 117:87 De Smet, P.A.G.M., 117:19 Freyburger, G., 118:603 Hasan, A.A.K., 117:229 Deguchi, Y., 117:615 Fries, D., 117:597 Hashizume, H., 117:615 Demaca, C., 118:543 Fukuhara, S., 117:385 Hasselblad, V., 117:439 Dempfle, C.-E., 118:569 Furmedge, J., St 7:279; Hathaway, W.E., 118:771 Dentali, S., 117:211 118:741 Hatseras, D.|., 118:221 Author Index Hatzinikolaou, E.I., 118:221 Jeung, M., 117:653 Kristof, V., 117:639 Hawkins, B., 117:211 Johnston, L., 118:587 Krusius, T., 118:603 Haznedar, R., 118:765 Jones, C., 118:755 Kudoh, T., 117:263 He, M., 117:579 Jung, S.M., 118:509 Kuismanen, K., 118:603 He, S., 117:579 Kumar, T.S., 117:419 He, X., 117:579 Kaaja, R., 118:705 Kuroda, K., 117:255 Heestermans, A.A.C.M., Kaczmarek, R., 118:691 Kveder, T., 118:455 118:769 Kahn, S.R., 117:609 Kiziltune, A., 117:357 Hennessey, M.D., 117:551 Kaloyannidis, P., 118:611 Hervig, T., 118:341 Kamali, F., 118:501 Labios, M., 117:403; 118:447 Hiltunen, L., 118:705 Kambayashi, J., 118:371 Labrouche, S., 118:603 Hjeltnes, N., 118:281 Kamikura, Y., 117:671 Lacut, K., 118:691 Ho Lee, S., 117:591 Kamphuis, J.S., 118:313 Laiho, M.K., 118:573 Hoffman, F.A., 117:177 Kaneko, T., 117:671 Lally, C., 118:767 Hogg, K.E., 118:547 Kang, H.N., 117:591 Laminoga, N., 118:595 Hohl, M., 118:229 Kang, J., 118:353 Landron, C., 117:365 Hoke, H.A., 118:747 Kang, M.-S., 118:353 Lane, D., 117:351 Holley, A.B., 117:563 Kang, M.S., 117:653 Lanza, G.A., 118:663 Holm, J., 118:213 Kani, S., 118:651 Lassila, R., 117:291; 118:241 Holmsen, H., 118:341 Karaca, Y., 117:357 Latella, C., 117:681 Hong, T.-T., 117:333 Karapolat, S., 117:357 Lazzari, M.A., 118:269 Hongo, M., 118:651 Kashiwakura, Y., 118:627 Le, S., 118:371 Hooper, W.C., 118:767 Kaski, J.C., 118:221 Le Gal, G., 118:691 Horne, M., 117:15 Kearon, C., 117:241 Lee, A., 117:103 Hou, S.-M., 118:439 Keating, F.K., 118:361 Lee, A.P., 117:155 Huang, C.-H., 118:439 Kemona, H., 118:199 Lee, D.H., 118:671 Huang, Y., 117:439 Kenet, G., 118:59 Lee, E., 117:419 Huber, A.R., 118:123 Khan, T., 118:501 Lee, K.W., 118:305 Hueb, W.A., 118:679 Kickler, T.S., 118:247 Lee, S., 117:419, 653 Huh, H.J., 117:501 Kierulf, P., 117:297 Lee, W.-J., 118:619 Hunt, R.W., 118:39 Kim, B.J., 118:671 Lee, W.-L., 118:619 Hurlen, M., 118:433 Kim, D.-S., 118:353 Lee, Y.-k., 117:419 Huttl, K., 117:639 Kim, K.-A., 118:353 Lee-Chen, G.-J., 118:235 Hwa Hong, S., 117:591 Kim, M.-J., 117:197 Leung, V., 118:763 Kim, N.K., 117:653 Levo, A., 118:603 lannaccaro, P., 117:681 Kim, S.K., 117:419 Lewis, D.A., 118:747 Ignjatovic, V., 118:741 Kingston, R., 117:119, 137 is. X... S¥Fioar ljiri, ¥., 117:411, 529 Klemp, K.F., 118:747 Liang, K.-W., 118:619 Ikari, Y., 117:615 Kliewer, S.A., 117:133 Lichtenstein, A.H., 117:71 lkarugi, H., 117:529 Kline, J.A., 118:547 Lijnen, H.R., 118:539 llveskero, S., 117:291 Ko, J.J., 117:653 Lim, W., 118:409 Imin, H., 118:733 Koh, S.B., 118:671 Lin, C.-¥., T0G2735 Inder, T.E., 118:39 Kohara, S., 117:647 Lindahl, T.L., 117:543 Isenbarger, D.W., 117:379 Kohler, H.P., 118:205 Lindsell, C.J., 117:603 Ishiwata, A., 118:627 Koide, T., 117:323 Linkins, L.-A., 117:241 Isler, |., 117:249 Kojima, S., 117:263 Lip, G.Y.H., 117:231, 351, 623; Israels, S.J., 118:75 Kojima-Aikawa, K., 117:255 118:185, 247, 301, 305, 321, Iversen, P.O., 118:281 Kokoglu, E., 117:249 429, 479 lwasaka, T., 117:385 Kolbitsch, C., 117:597 Lippi, G., 117:731 Konstantinou, V., 118:535 Lipska, A., 118:199 Jackson, J.L., 117:563 Kortsaris, A., 118:221 Liu, T.-J., 118:619 Jacobson, L., 118:771 Kostousov, V., 118:723 Lo, D.S., 118:385 Jambou, D., 117:721 Kotian, P., 117:343 Lobato, M., 117:271 Jang, S., 117:501 Krahn, E.L., 117:507 Lockyer, S., 118:371 Jang, Y., 118:353 Kramkowski, K., 117:557 Lombardo, V.T., 117:681 Jani, J.T., 118:247 Krieger, J.E., 118:679 Lopes, N.H., 118:679 IV Author Index Lorenz, |.H., 117:597 Molinari, A.C., 117:685 Odén, A., 117:493 Louridas, G., 118:535 Molnar, A.A., 117:639 Ogawa, H., 117:263 Lubenow, N., 117:507 Monagle, P., 118:1, 587, 741 Oger, E., 118:691 Luca Salvagno, G., 117:731 Monagle, P.T., 117:279 Oguni, S., 118:463 Lucchesi, B.R., 117:333 Monos, E., 117:639 Oh, D., 117:653 Luderitz, B., 117:371 Mont, L., 117:235 Ohmori, T., 118:627 Ludlam, C.A., 118:189 Montagnana, M., 117:731 Ohnuma, M., 118:509 Lui, W., 118:763 Monteagudo, J., 117:235 Okada, M., 118:715 Luis Marin, J., 117:235 Moon, H.T., 117:419 Okada, T., 118:627 Luise, F., 117:681 Moore, G.W., 118:523 Okumura, N., 118:651 Moore, N., 118:733 Okumura, T., 117:615 Ma, J., 118:709 Moores, L.K., 117:563 Okuyama, K., 118:371 Ma, Y., 117:537 Morboeuf, O., 117:523 Ollenberger, G.P., 118:685 Madoiwa, S., 118:627 Morgenstern, E., 117:393 Olsson, $.B., 117:713 Maffei, S., 118:487 Morild, |., 118:341 Omoto, S., 117:385 Magnani, H.N., 117:507 Morishita, Y., 118:463 On behalf of the CLE-PTS Inves- Malik, M., 118:595 Moroi, M., 118:509 tigators, 118:699 Mammi, C., 117:681 Moser, P.L., 117:597 Onishi, K., 118:463 Man Hong, C., 117:591 Mottier, D., 118:691 Oriana, V., 117:681 Manco-Johnson, M.J., 118:771 Muenchen, R.A., 117:551 Grtet, T.h., OUFiz7a,. 20% Mancone, M., 117:659 Muleo, G., 117:681 118:747 Manes, C., 118:471 Mulligan-Kehoe, M.J., 117:483 Osmond, P.J., 118:263 Manic, H., 117:365 Murakami, M., 117:255 Oster, G., 117:569 Marchi, R., 118:637 Mussigang, P.R., 117:597 O’Sullivan Maillet, J., 117:211 Marcucci, R., 118:495 Mysliwiec, M., 117:517 Owers, R.L., 117:551 Marder, V.J., 117:7, 155, 229 Ozaki, Y., 117:263 Mariani, P., 117:659 Nadasy, G.L., 117:639 Ozawa, K., 118:627 Markiewicz, M., 118:595 Naemura, A., 117:411, 529 Martinez, M., 117:403; 118:447 Nagamitsu, H., 117:323 Paccalin, M., 117:365 Massicotte, M.P., 118:153 Naka, H., 118:627 Pagnan, A., 117:523 Masuda, J., 117:255 Nakane, M., 118:709 Palareti, G., 118:667 Matowicka-Karna, J., 118:199 Nakanishi, K., 117:255 Pallares, E., 118:335 Matsui, K., 117:263 Nakanishi, T., 118:715 Palmer, M.E., 117:33 Matsumoto, |., 117:255 Nakashima, M., 118:715 Paola Cellai, A., 118:495 Matsumoto, Y., 118:371 Nakatani, K., 118:463 Paoli, F., 118:487 Mattsson, C., 117:543 Nam Kim, S., 117:591 Pan, S., 11#2315 Matzdorff, A., 117:307, 393 Naritomi, H., 118:290 Paradossi, U., 118:487 McCrindle, B.W., 118:49 Nasrallah, A., 117:631 Park, C.J., 117:501 McDonald, J., 117:665 Nasser, M., 117:271 Park, K.W., 118:671 McGlasson, D., 118:529 Nava, S., 117:235 Park, M.H., 118:671 Meguro, S., 117:411 Navarro, J.L., 118:335 Park, M.K., 118:671 Mercie, M., 117:365 Newall, F., 117:279; 118:113, Parker, C., 117:343 Meyer, M., 118:637 587, 741 Paroli, M., 117:659 Michelsen, A.E., 117:705 Newby, D.E., 118:189 Parri, M.S., 118:487 Michelson, A.D., 118:75 Niimura, M., 118:627 Partanen, J., 118:603 Milanov, S., 118:595 Nishikawa, M., 117:385 Patch, D., 118:595 Milligan, P.E., 117:55 Nishioka, J., 117:671; 118:463 Patel, J.V., 118:247 Mimuro, J., 118:627 Nobori, T., 117:671; 118:463 Paton, C.M., 118:263 Min, J.Y., 118:671 Nolan Jr., P.E., 117:155 Patteson, S.K., 117:551 Minematsu, K., 118:290 Nomura, S., 117:385 Pawlak, D., 117:517 Miro, O., 117:235 Nordvik, A., 118:341 Pawlak, K., 117:517 Miyamoto, S., 117:263 Norris, L.A., 117:283, 475 Pearse, L.A., 117:379 Mizukami, H., 118:627 Nugent, A., 117:475 Peddada, S.D., 118:747 Mogielnicki, A., 117:557 Nylander, S., 117:543 Pederiva, S., 118:229 Mohan, J.S., 117:623 Nyska, A., 118:747 Peltola, O., 118:573 Author Index Penzak, S.R., 117:155 Saint-Jacques, H., 117:439 Sobel, B.E., 118:361 Pereira, A.C., 118:679 Saka, E., 118:289 Sofi, F., 118:545 Persson, H.W., 117:713 Sakaguchi, A., 117:671; Sofronas, M., 118:153 Perutelli, PR, 117:685 118:463 Sohal, A.S., 118:417, 423 Peternel, P., 118:455 Sakamoto, T., 117:263 Soltani, S., 117:665 Peters, M., 118:13 Sakata, Y., 118:627 Song, K.-S., 118:353 Pettersson, K., 118:573 Sakellari, |., 118:611 Song, K.S., 117:732 Pierro, M., 117:659 Sanchez, M., 117:235 Sonmez, H., 117:249 Piromalli, A., 117:681 Sandset, P.M., 118:281, 297 Sonoda, M., 118:509 Pizzulli, L., 117:371 Santoro, R., 117:681 Soria, J., 118:637 Platikanov, V., 118:595 Sardella, G., 117:659 Sottilotta, G., 117:681 Ploeger, B., 118:313 Sase, T., 117:671 Spinler, S.A., 117:155 Poredos, P., 118:455 Satoh, A., 117:255 Stakos, D.A., 118:221 Porretta, A., 117:659 Savidge, G.F., 118:523 Stalc, M., 118:455 Posch, A., 118:247 Savoia, H., 117:279 Stenflo, J., 118:213 Postlethwaite, A.E., 117:299 Sawaya, F.J., 117:631 Stokke, O., 117:705 Potti, A., 118:747 Sbrana, S., 118:487 Strandberg, K., 118:213 Préda, |., 117:639 Scalise, A., 117:235 Streif, W., 117:597 Prins, A.-M., 118:691 Schattenkerk, M.E., 118:313 Strengers, P.F.W., 118:313 Prisco, D., 118:495 Schena, F., 117:731 Stretton, R., 117:241 Probyn, L., 117:241 Schettert, |.T., 118:679 Sturgeon, S.A., 118:755 Prydz, H., 117:343 Schmid, H.R., 118:229 Sucak, G.T., 118:765 Pucino, F., 117:87 Schmidt, B., 118:107 Sugiyama, S., 117:263 Puech-Leao, P., 117:271 Schmugge, M., 118:123 Sun, B., 118:371 Punnonen, K., 118:573 Schneider, D.J., 118:361 Sunderland, E., 117:87 Punwani, C., 118:341 Schnurer, C., 117:597 Sutherland, J.S., 117:447 Puurunen, M., 118:241 Schouten, T.J., 118:313 Suzuki, K., 117:255; 118:715 Puzantian, H., 117:631 Schroeder, V., 118:205 Schwartz, G.N., 117:483 Takada, K., 118:715 Quinn, M.P., 117:551 Schwertner, H.A., 118:529 Takano, K., 118:627 Sciartilli, A., 118:471 Takayama, E., 117:255 Rabbat, C.G., 118:385 Scott, P.T., 117:379 Takayama, H., 117:299 Radziwon, P., 118:199 Sebestjen, M., 118:455 Tanabe, T., 117:615 Rainaho, J., 118:573 Seljeflot, |., 118:433 Tandon, N.N., 118:371 Ramacciotti, E., 118:699 Sestito, A., 118:663 Tapson, V., 117:155 Ramirez, F., 117:681 Softeland, E., 118:341 Taylor, A.J., 117:379 Rasi, V., 118:603 Sgueglia, G.A., 118:663 Ten Berg, J.M., 118:769 Rasmussen, J.M., 118:263 Shaw, G.J., 117:603 Tentes, |.K., 118:221 Rautanen, A., 118:705 Shbaklo, H., 117:631 Terasawa, F., 118:651 Rebecca Couris, R., 117:25 Sheffield, W.P., 117:447 Thorsen, T., 118:341 Reddy, S., 118:247 Sheu, W.H.-H., 118:619 Thrall, G., 117:351 Revel-Vilk, S., 118:59 Shiku, H., 117:671 Ting, C.-T., 118:619 Ricart, J.M., 117:355 Shim, E.H., 117:501 Todoli, J., 117:355 Righini, M., 118:691 Shimizu, M., 117:647 Tognin, G., 117:523 Risch, L., 118:123 Shina, Y., 117:615 Tohti, |., 118:733 Ro, L.-S., 118:235 Shinohara, T., 118:715 Tokimitsu, |., 117:411 Roberts, S., 118:767 Shinohara, Y., 117:647 Tokunaga, F., 117:323 Roblot, P., 117:365 Shouzu, A., 117:385 Tomatsu, H., 118:463 Roche, H.M., 117:475 Simioni, P., 117:523 Tomsic, M., 118:455 Rodger, M.A., 117:469 Singhal, R., 118:397 Tormene, D., 117:523 Rosoky, R.A., 117:271 Sitges, M., 117:235 Toulon, P., 117:721 Rubi, J., 118:335 Sloane, D.-A., 117:507 Treleaven, D., 118:417, 423 Ruiz-Aja, S., 117:403 Smias, C., 118:611 Truzzi, A., 118:699 Ruiz-Saez, A., 118:637 Snider, C.C., 117:551 Tseng, M.T., 118:275 Vi Author Index Tsuda, S., 117:323 Waas, W., 117:393 Wright, C.E., 118:755 Turdi, S., 118:733 Wada, H., 117:671; 118:463 Wu, J., 118:747 Tursun, M., 118:733 Wajngarten, M., 117:271 Wu, K.K., 117:61 Tziakas, D.N., 118:221 Wang, H., 117:315 Wu, Y.-R., 118:235 Wang, P.-C., 118:439 Wuillemin, W.A., 118:205 Uint, L., 117:271 Ward, A., 118:501 Wu-Wong, J.R., 118:709 Ulander, V.-M., 118:705 Ward, S.M., 118:747 Wynn, R.F., 118:27 Ulutin, T., 117:249 Warkentin, T.E., 117:507; Wynne, H., 118:501 Umar, A., 118:733 118:165 Unli, Y., 117:357 Wartiovaara, U., 118:705 Xie, Q., 117:579 Upshaw, R., 117:343 Watanabe, H., 117:411 Ural, A.U., 118:665 Watanabe, N., 118:509 Yabu, Y., 118:463 Watanabe, T., 118:371 Yagci, M., 118:765 Vahtera, E., 118:603 Weisel, J.W., 118:637 Yamaguchi, M., 117:671 Vaishali, B., 117:419 Weldon, S., 117:475 Yamamoto, J., 117:411, 529 Van Aart, L., 118:313 Wells, P.S., 117:469; 118:253 Yamamecto, M., 117:647 Van Gorp, C.L., 117:333 Wergeland, R., 117:705 Yamashita, T., 117:411, 529 Van Ommen, C.H., 118:13 Wesley, R., 117:87 Yang, A., 117:371 Van Walraven, C., 118:253 Wessel, A., 117:507 Yannaki, E., 118:611 Van Werkum, J.W., 118:769 Whitaker, D.A., 118:361 Yasaka, M., 118:290 Varma, C., 118:185, 429 Whitsett, C., 118:767 Yoneda, M., 117:283 Vaya, A., 117:355 Wiernikowski, J.T., 118:137 Yoosef Seyedna, S., 118:505 Vazquez, C., 117:487 Wiman, B., 117:315 Yoshimura, M., 117:263 Velan, T., 117:689 Wisloff, F., 118:297 Yoshioka, A., 118:627 Velik-Salchner, C., 117:597; Wittkowsky, A., 117:155 Yoshitake, M., 118:371 118:295 Wittkowsky, A.K., 117:81 Young, J., 117:211 Veneri, D., 118:177 Wolosker, N., 117:271 Yuan, C.-S., 117:49 Vera-Llonch, M., 117:569 Womack, C.J., 118:263 Vergos, J.-C., 118:691 Wong, K., 117:537 Zacharski, L.R., 117:483 Vickers, D.G., 118:263 Wong, R.S.M., 118:763 Zaffanello, M., 118:177 Villines, T.C., 117:379 Woo, J.J.Y., 117:193 Zalloua, P.A., 117:631 Vilstrup, H., 118:595 Wood, P., 118:501 Zeerleder, S., 118:205 Von Lode, P., 118:573 Woodhams, B., 117:523 Zeinali, S., 118:505 Voss, R., 117:307, 393 Worsley, D.F., 118:685 Ziakas, A., 118:535 Thrombosis Research (2006) 118, VIl—X THROMBOSIS RESEARCH " he ELSEVIER intl.elsevierheaith.com/journals/thre y319, 118:651 Annexin, 117:255 Bradykinin receptor, 117:551 Annexin V, 117:537 Breast cancer, 117:487 A3 haplotype, 117:523 Anticoagulant therapy, 118:137 2-butoxyethanol, 118:747 AA (aplastic anemia), 118:463 Anticoagulants, 118:361 ABO blood group, 117:665 Anticoagulation, 117:493; CAD, 117:439 Accuracy of coding, 118:253 118:113, 301, 501 Calcium, 117:537 ACE-Is, 117:557 Anti-Factor lla, 118:741 Cancer, 118:555 Acenocoumarol, 118:85 Anti-Factor Xa, 118:741 Cancer in children, 118:137 Activated protein C, 118:213 Antiphospholipid antibodies, Capacity, 117:639 Activated protein C resistance, 117:365 Cardiopulmonary bypass, 117: 118:269 Antiphospholipid syndrome, 689 Activated Protein C Resistance, 117:365 Cardiovascular disease, 118: 117:665 Antiplasmin, 117:315 471, 709 Acute coronary syndrome, Antithrombin, 118:107, 235, Cardiovascular events, 118:679 118:409 611 Cardioversion, 117:235; 118: Acute mesenteric ischemia, Antithrombin concentrate, 479 117:463 117:591 Carotid artery plaque, 117:615 Acute myocardial infarction, Antithrombotic medications, Carotid sonography, 117:647 118:495 118:153 Catheter thrombosis, 118:439 Acute reversal of anticoagulant Apolipoprotein E, 117:411 CD14, 118:671 drugs, 118:313 APTT, 118:741 CD40 ligand, 118:619 ADAMTS-13, 117:685 Arg359X mutation, 118:235 CD62P, 117:393, 647 Adeno-associated virus, 118: Arterial thrombosis, 118:733 Cerebral infraction, 117:647 627 Artery, 118:755 Cerebral venous thrombosis, Adenosine diphosphate, 118: Aspirin, 118:75, 321, 433, 471, 118:235 341 529 Chemotherapy, 117:671; 118: Adhesion, 118:371 Atherosclerosis, 117:271, 357, 137, 555 ADP, 117:543; 118:733 411, 475, 529; 118:455 Child, 118:13 Adults, 117:609 Atherosclerotic marker, Childhood ischaemic stroke, Age, 117:665 117:385 118:67 Aggregation, 117:291; 118:371 Atrial fibrillation, 117:235, Children, 118:75, 85, 95, 123, Analyzer, 117:721 493; 118:321 153, 587, 741 Ancrod, 117:507 Axillary vein, 117:639 Chronic renal disease, 118:709 Angioplasty, 117:371 Chronic renal insufficiency, Angiotensin Il, 117:579 Bleeding, 117:569; 118:417, 118:409 Angiotensin receptor, 117:579 423, 755 Circadian variation, 118:281 Animal models, 118:747 Bleeding time, 118:371 Circulating endothelial cells Ankle brachial index, 117:263, Bone marrow transplantation, (CECs), 118:479 357 118:611 Clinical assessment, 117:469 doi: 10.1016/S0049-3848(06)00383-5 Vill Keyword Index Clinical prediction rules, 118: Drug-eluting stents, 117:659 GE-XDP, 117:671 685 DX-9065a, 117:439 Glucocorticoids, 118:247 Clinical predictive rules, 117: Dysfibrinogen, 118:651 (s2-Glycoprotein |, 117:255 469 Dysfibrinogenemia, 118:637 GP llb/Illa, 117:291 Clot structure, 118:637 Dysfunctional PC, 117:523 GP IIb/Illa inhibitors, 117:307 Coagulation, 117:291, 357, 721 GP VI, 117:291 Coagulation activity, 118:213 Endothelial dysfunction, 117: GPVI, 118:509 Coagulation factors, 118:247, 529 GPVI-knockout, 118:371 269, 313 Endothelial function, 118:455 Guidewire exchange, 118:439 Coagulation parameters, 117: Endothelium, 117:235, 271; 597 118:275 Haemodialysis, 117:517 Cofact®, 118:313 Endotoxin, 117:429 Haemostasis, 117:557; 118: Collagen, 117:299 End-stage renal disease, 118: 313 Common carotid artery, 118: 423 Health economics, 118:699 275 EPCR gene, 117:523 Helicobacter pylori, 118:671 Common femoral vein, 117:639 ERAD, 117:323 Hemolysis, 118:747 Computer modeling, 117:689 ER-mannosidase |, 117:323 Hemophilia, 118:627 Conjugate, 117:419 E-selectin, 118:479 Hemophilia A, 118:505 Coronary angioplasty, 117:393 Ethics, 118:153 Hemorrhage, 117:569; 118: Coronary artery disease, Evaluation, 117:721 547 117:249, 501, 631; 118:495 Hemostasis, 118:595 Cost analysis, 117:569; 118:699 Factor Vil, 117:343 Hemostatic regulation, 117:689 Costs, 117:569 Factor Vill, 118:505, 627 Heparin, 117:429, 447; Coumarin, 117:507 Factor Xa inhibitors, 117:439 118:611, 741 C-reactive protein, 117:343 Familial thrombophilia, 117: Heparin cofactor Il, 117:447 Critical limb ischemia, 117:271 665 Heparin-induced thrombocyto- Cyclic flow reductions, 118:755 Fasting blood glucose, 117:631 penia, 117:507; 118:123, 165 FeCl,, 118:275 High fat diet, 117:529 Danaparoid, 117:507 Fibrin clot formation, 118:651 Hirudin, 118:241 p-Dimer, 117:283 Fibrinogen, 118:305 Home monitoring, 118:587 D-dimer, 117:463, 469; 118:353 Fibrinolysis, 117:487, 713; Homocysteine, 117:501, 653 D-Dimer, 118:573 118:189, 495, 637, 651 hs-CRP, 118:619 De novo insertion, 118:439 Fibrinolysis inhibitor, 118:495 Human test kit, 117:597 Decision-making, 118:547 Fibrinolytic system, 117:517 Human umbilical vein endothe- Deep vein thrombosis, 118:699, Fibronectin, 117:249 lial cell, 118:715 763 Finnish population, 118:603 Hypertension, 117:385, 403, Deep venous thrombosis, Fletcher factor, 118:765 615; 118:447 117:609 Flow cytometry, 117:307, 393, Hypothermia, 117:603 320 deletion, 118:651 403, 543 Hysterectomy, 118:229 Deoxycholic acid, 117:419 Flow mediated dilation of bra- Dexamethasone, 117:429 chial artery, 118:455 Immunoassay, 118:573 Diacylglycerol, 117:411 Flow-mediated vasodilation, In vitro, 117:713; 118:733 Diagnosis, 117:731; 118:13 117:529 In vivo, 118:733 Diagnostic performance, 118: Folate, 117:501 Inappropriate prescriptions, 685 Folts model, 118:755 118:471 Dilution effect, 118:523 Formaldehyde, 117:537 Incidence, 118:13 Direct thrombin inhibitor, Formulations, 118:529 Infant newborn, 118:107 118:165 Free calcium mobilization, Infants, 118:153 Discharge abstracts, 118:253 117:403 Inflammation, 117:357, 659; Disseminated intravascular Fresh-frozen plasma, 118:611 118:305 coagulation, 117:255, 429 INR, 117:493 Distensibility, 117:639 Gender, 117:665 Integrin activation, 118:509 D-monomer, 118:353 Gene expression, 118:715 Interleukin-1,, 117:659 DMSO, 117:419 Gene therapy, 118:627 Interleukin-6, 117:343, 659; Doxazosin, 118:447 Genetic prothrombotic muta- 118:305 Doxazosin GITS, 117:403 tion, 117:681 Interleukin-8, 117:343 Keyword Index Intermittent claudication, 117: Monoclonal antibody, 118:353 PFA-100, 118:229, 487 271 Monocyte, 117:579 Pharmacokinetics, 118:529 Internal jugular vein, 117:639 Monocyte chemotactic protein Phenprocoumon, 118:85 International normalised ratio, 1, 118:619 Phosphatidylserine, 117:537 118:113 Monocytes, 117:475 Pigs, 117:597 International Normalised Ratio MTHFR, 117:653 Plaque instability, 118:221 (INR), 118:587 Mutation, 118:603 Plasma arginine—vasopressin, Interobserver agreement, 117: Myocardial infarction, 118:189, 118:229 241 213, 305, 433 Plasma concentrations, 118:529 Intraventricular hemorrhage, Plasminogen activator inhibitor, 118:107 National biological standard, 118:263 IPF (immature platelet frac- 117:591 Plasmin/plasminogen, 118:221 tion), 118:463 Neo-epitope, 118:353 Platelet, 117:299; 118:371 lranian population, 118:505 Neonates, 118:123 Platelet activating factor, 118: ITP (idiopathic thrombocyto- Nephropathy, 117:385 341 penic purpura), 118:463 Newborns, 118:95 Platelet activation, 117:307, Nitric oxide, 117:249 403, 647; 118:447, 487 Laboratory assessment, 117: Nitrotyrosine, 117:299 Platelet activity, 117:371 665 Normal reference ranges, Platelet aggregation, 117:249, Lactate, 118:335 117:665 263, 299, 333, 615; 118:529, Laparoscopy, 118:229 Normal values, 117:597 733 Leukocyte, 117:671 Nuclear factor-«B, 117:579 Platelet count, 117:371; 118: Leukocytes, 118:361 199 Lipoprotein (a), 117:631 Occult bleeding, 118:433 Platelet function, 118:229, 335 Liver failure, 118:595 Ocimum basilicum L., 118:733 Platelet polymorphism, 118: LMWH, 117:283 Omega-3 fatty acids, 118:305 679 Low molecular weight heparin, Oral anticoagulants, 118:85 Platelet P-selectin, 117:623 117:419 Oral delivery, 117:419 Platelet volume, 117:371 Low-density lipoprotein defi- Orthopedic surgery, 117:569 Platelet-derived micropar- cient mice, 117:411 Outcome, 118:13 ticles, 117:705 Low-molecular-weight heparin, Outcomes, 117:569 Platelets, 117:291, 393, 411, 118:409 Oxidative stress, 117:517 537, 543, 705; 118:75, 165, Lupus anticoagulant, 118:523 341, 361, 509 PAC-1, 117:647 Point-of-care monitoring, 118: Malignant lymphoma, 117:671 Paediatric, 118:113 113 Matrix metalloproteinases, PAI-1, 117:487; 118:205, 495, Point-of-Care (POC), 118:587 118:221 709 Point-of-care testing, 118:573 Mean platelet volume, 118:199 PAl-1 gene polymorphism, Polymorphism, 118:671 Mechanisms, 118:417 117:487 Postthrombotic state, 117:639 Melagatran, 117:429 PAP, 117:283 Post-thrombotic syndrome, Mesenterial venous thrombosis, Paraformaldehyde, 117:537 117:609; 118:699 118:241 Pathophysiology, 118:417 Potentiation of platelet colla- Meta-analysis, 118:321 Patient education, 118:587 gen activation, 117:551 Methyltetrahydrofolate reduc- Patient location, 118:685 Preeclampsia, 117:551 tase, 117:501 PCC, 118:313 Pregnancy, 117:255, 283 Microaggregate formation, PCI, 118:487 Primary antiphospholipid syn- 118:447 Pediatric, 118:59 drome, 118:455 Microarray, 118:715 Pediatric clinical trials, 118:153 Primary prevention, 118:471 Microscopy, 118:341 Percutaneous revascularization, Primary thrombocythemia, Microvascular thrombosis, 118:361 118:335 118:747 Peripheral arterial disease, PROC gene, 118:603 Military, 117:379 117:263, 357; 118:619 Prolonged activated partial Mixing studies, 118:523 Peritoneal dialysis, 117:517 thromboplastin time, 118: Modified thrombelastography Persistent atrial fibrillation, 765 (ROTEM* ), 117:597 118:479 Protease inhibitors, 117:447 MODS, 118:205 PF4, 118:165 Proteasome, 117:323 Keyword Index Protein C, 118:603, 611 Sickle cell disease, 117:623; Tissue-type plasminogen activa- Protein C inhibitor, 118:213 118:747 tor, 118:651 Protein S mutant, 117:323 Signal transduction pathway, Treatment, 118:423 Prothrombin complex concen- 117:579 Treatment threshold, 118:547 trates, 118:313 Site-directed mutagenesis, TR-IFMA, 117:705 Prothrombotic abnormalities, 117:315 Tripeptidyl peptidase Il, 117: 118:67 Soluble P-selectin, 117:623 323 Pulmonary embolism, 117:469; Soluble thrombomodulin, 118: TSER, 117:653 118:13, 547, 685 479 Type 2 diabetes mellitus, 117: P2Y,, 117:543 Southwest Asia, 117:379 385 P2Y12, 118:679 St14 VNTR, 118:505 P2Y12, 117:543 Stability, 117:315 Ultrasound, 117:241, 603, 713 Stillbirth, 117:681 Unfractionated heparin, 118: Streptokinase, 117:713 165 Rap1, 118:509 Stroke, 117:493, 603; 118:75, Unstable angina, 118:495 Rat, 118:733 153, 671 Upper extremity, 117:609 Rats, 117:557; 118:755 Subclavian vein re-catheteriza- Upper gastrointestinal bleed- Real-time PCR, 118:715 tion, 118:439 ing, 118:595 Receptor, 117:299 Swine, 118:341 Uremia, 118:417, 423 Recurrent, 118:235 Sysmex CA-7000, 117:721 Urinary trypsin inhibitor (Biku- Recurrent deep vein thrombosis, Systematic review, 118:321 nin), 117:255 117:241 Recurrent pregnancy loss, 117: TAFI, 118:205, 495 Valsalva, 117:639 681 TAT, 117:283 Valsartan, 117:385 Recurrent spontaneous abortion Tetraplegia, 118:281 Vasodilation, 117:529 (RSA), 117:653 TF, 117:671 Veins, 117:639 Reference ranges, 118:523 Therapy, 118:13 Veno-occlusive disease, 118:611 Release reaction, 118:509 y-thrombin, 117:333 Venous, 117:379 Reperfusion, 118:189 Thrombin, 117:439, 447, 543; Venous thromboembolism, 117: Respiratory distress syndrome, 118:715, 733 731; 118:59, 409, 555 118:107 Thrombocytopoietic indices, Venous thrombosis, 118:547, Restenosis, 117:371 118:199 603 Rethrombosis, 117:333 Thromboembolism, 117:379; Vitamin C, 118:501 Reticulated platelet, 118:463 118:95, 137 Vitamin D analogs, 118:709 Retinal vein occlusion, 117:365 Thrombogenesis, 118:305 Vitamin D receptor, 118:709 Review article, 117:609 Thrombolysis, 117:333; 118:95, Vitamin K antagonists, 118: rFVila, 118:595 221 301 Rheological properties, 118:637 Thrombolytic therapy, 118:95 Von Willebrand disease, 117: Risk factor, 118:679 Thrombomodulin, 117:271 685 Rotational atherectomy, 117: Thrombophilia, 117:523; 118: Von Willebrand factor, 117:685; 393 59 118:479 Thrombopoietin, 117:551 V/Q scan, 118:685 Safety, 117:469 Thromboprophylaxis, 118:699 VTE, 117:569 Salicylic acid, 118:529 Thrombosis, 117:255, 343, 411, Scintigraphy, 118:341 Sar; VtGc7a, Ge, Fe, 22, Warfarin, 117:493; 118:85, 113, SEPCR levels, 117:523 247, 269, 275, 555, 755 321, 433 Sepsis, 118:107, 205 Time-resolved fluorometry, Warfarin complications, 118: Serpin, 117:315 118:573 253 Serpins, 117:447 Tissue factor, 117:343, 475, 579 Sex, 118:199 Tissue factor pathway inhibitor Ximelagatran, 118:301, 321 Shear stress, 118:447 (TFPI), 118:281 X-ray microanalysis, 118:275 Shear-induced platelet aggrega- Tissue plasminogen activator, tion, 117:529 118:263